...
首页> 外文期刊>Journal of Health, Medicine and Nursing >In Vivo Analysis of Therapeutic Effects of Hydroxychloroquine, Azithromycin, Paracetamol, Dexamethasone, Remdesivir and Tocilizumab in Patients Affected with Novel Covid-19
【24h】

In Vivo Analysis of Therapeutic Effects of Hydroxychloroquine, Azithromycin, Paracetamol, Dexamethasone, Remdesivir and Tocilizumab in Patients Affected with Novel Covid-19

机译:对新型Covid-19影响的羟基氯喹,阿奇霉素,扑热息痛,地塞米松,甲酰胺,甲酰胺,雷达虫草和对照中的对照分析

获取原文
           

摘要

COVID 19 creates pandemic around the globe. This virus spread so rapidly and unfortunately till now there is no authentic treatment available. Based upon the trials various drugs were applied to control the disease. Different drugs found effective including hydroxychloroquine, dexamethasone, azithromycin and remdesivir. In current study 100 patients were participated. The presence of disease was confirmed by PCR based tests. Initials reports represent various abnormal range of WBC’s in patients. Most of them were symptomatic while few were asymptomatic. Gender wise COVID-19 mostly affected males rather than female gender. It was also found that older person were more susceptible than younger one.Effectiveness of the drugs shows there is need to do more work on following components to control the disease prevalence until a vaccine is discovered.
机译:Covid 19在全球范围内创造了大流行。这种病毒迅速蔓延,不幸的是直到现在没有可用的真实治疗。基于试验,应用各种药物来控制疾病。不同的药物发现有效,包括羟基氯喹,地塞米松,阿奇霉素和雷德替代。目前研究100名患者参加了100名患者。通过基于PCR的试验证实了疾病的存在。缩写报告代表患者中的各种异常范围。其中大多数是症状,而少数是无症状的。性别明智的Covid-19主要受到男性的影响而不是女性性别。还发现老年人比较年轻人更容易受到敏感。药物的效果表明,在发现疫苗之前,需要做更多的作用以控制疾病患病率。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号